Drug approval processes in Australian Paediatric Hospitals.

Area of Science:

• Health Services Research
• Paediatric Pharmacology
• Hospital Pharmacy Administration

Background:

• Drug approval processes in paediatric hospitals are critical for patient safety and resource allocation.
• Understanding decision-making variations is essential for optimizing formulary management.

Purpose of the Study:

• To describe and evaluate drug approval decision-making processes within Australian paediatric hospitals.
• To identify variations in workload, expenditure, and approval rates.

Main Methods:

• A multicentre descriptive study was conducted across all eight Australian paediatric hospitals.
• Data collection involved interviews with committee chairs/secretaries and review of committee documents and drug submissions over one year.
• Key metrics included drug expenditure, formulary submissions, and individual-patient use approvals.

Main Results:

• High drug approval rates (76%-100%) were observed, with no significant inter-hospital differences for formulary submissions.
• Individual-patient use applications varied widely (10-456 per hospital), with variable approval rates.
• Quality of evidence was prioritized over cost; however, infrastructural support was often inadequate, and pharmaco-economic evaluations were absent.

Conclusions:

• Most drug submissions are approved in Australian paediatric hospitals, but significant variations exist in workload and resource allocation.
• Duplication of effort is evident, and many drug and therapeutics committees are under-resourced.
• Improvements in infrastructural support and formal evaluation methods are needed.